Thursday, July 27, 2023

Magnaspartate 243 Mg Powder For Oral Solution

Magnaspartate 243 Mg Powder For Oral Solution. Each sachet contains 2.706g sucrose and 2mg sodium. Each sachet contains 2.706g sucrose.

Products Kora Healthcare
Products Kora Healthcare from www.korahealthcare.com

Each 6.5 g sachet of powder contains magnesium aspartate dihydrate equivalent to 243 mg (10 mmol) of magnesium. Magnaspartate® (magnesium aspartate dihydrate) 243 mg powder for oral solution: Each sachet contains 2.706g sucrose.

Magnaspartate 243 Mg Powder For Oral Solution.


Qualitative and quantitative composition each 6.5 g sachet of powder contains magnesium aspartate dihydrate equivalent to 243 mg (10 mmol) of magnesium. For the full list of excipients, see section 6.1. The maximum concentration for peripheral administration must not exceed 200 mg/ml (0.8 mmol/ml).

Magnesium Aspartate Dehydrate (Magnaspartate®) Equivalent To 243 Mg (10 Mmol) Of Magnesium Powder For Oral Solution Is The First Licensed Oral Magnesium Product Available In The Uk For The Treatment And Prevention Of Magnesium Deficiency.


This section provides information about magnaspartate ® 243mg powder for oral solution (magnesium aspartate dihydrate). Each sachet contains 2.706g sucrose for the full list of excipients, see section 6.1. Each sachet contains 2,706g sucrose , for the full list of excipients, see section 6,1, package leaflet:

Each Sachet Contains 2.706G Sucrose.


2 qualitative and quantitative composition. 15/05/2015 kora corporation ltd t/a kora healthcare: Patients and carers should be given advice on how to administer magnesium aspartate powder.

There Can Be Variation In The Licensing Of Different Medicines Containing The Same Drug.


Magnaspartate 243 mg powder for oral solution 2. Information for the user magnaspartate. Each 6.5 g sachet of powder contains magnesium aspartate dihydrate equivalent to 243 mg (10 mmol) of magnesium.

Licence Holder Kora Corporation Ltd T/A Kora Healthcare.


Magnaspartate 243 mg is contraindicated in patients with severe renal impairment. Trade name magnaspartate 243 mg powder for oral solution. Excipient (s) with known effect:

Labels: , , ,

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home